SavedAdd your journal

Journals / Turkish Journal of Internal Medicine / 2026 / Volume: 4 Special Issue

Pityriasis Rosea After Pfizer-BioNTech Covid-19 Vaccine: A Case Report

Şeyma Handan Akyön(Sağlık Bilimleri Üniversitesi, Ankara Şehir Hastanesi, Ankara, Türkiye)0000-0002-2288-8915
Yeşer Genç(Ankara Şehir Hastanesi)0000-0002-2909-4886
Pages
—
Publication Date
2022-04-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We presented a female case who developed pityriasis rosea after administering the 3rd dose of the Pfizer-BioNTech COVID-19 vaccine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:After the pandemic started, vaccines against SARS-CoV-2 were developed and applied in a short time.
📊
Key Findings & Data:Later, various side effects were reported during the use of these vaccines.
💡
Conclusion & Impact:We presented a female case who developed pityriasis rosea after administering the 3rd dose of the Pfizer-BioNTech COVID-19 vaccine.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:COVİD-19 Vaccines · Pityriasis Rosea · Pfizer Covid-19 Vaccine

Abstract

After the pandemic started, vaccines against SARS-CoV-2 were developed and applied in a short time. Later, various side effects were reported during the use of these vaccines. Among the skin side effects, besides local skin reactions at the injection site, urticaria, maculopapular rash and pityriasis rosea-like reactions were observed. We presented a female case who developed pityriasis rosea after administering the 3rd dose of the Pfizer-BioNTech COVID-19 vaccine.

🔖

Cite This Article

Akyön, Ş. H., Genç, Y. (2022). Pityriasis Rosea After Pfizer-BioNTech Covid-19 Vaccine: A Case Report. Turkish Journal of Internal Medicine, Volume: 4 Special Issue. https://doi.org/10.46310/tjim.1072232

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Rothan H, Byrareddy S. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433.
  2. Wang C, Horby P, Hayden F, Gao G. A novel coronavirus outbreak of global health concern. Lancet. 2020 Feb 15;395(10223):470-3. doi: 10.1016/S0140-6736(20)30185-9.
  3. GuanWJ,NiZY,HuY,LiangWH,OuCQ,HeJX,LiuL, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-20. doi: 10.1056/ NEJMoa2002032.
  4. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213. doi: 10.1111/jdv.16387.
  5. Galván Casas C, Català A, Carretero Hernández G, Rodríguez- Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, Navarro Fernández I, Ruiz-Villaverde R, Falkenhain-López D, Llamas Velasco M, García-Gavín J, Baniandrés O, González-Cruz C, et.al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020 Jul;183(1):71-7. doi: 10.1111/bjd.19163.
  6. Veraldi S, Romagnuolo M, Benzecry V. Pityriasis rosea-like eruption revealing COVID-19. Australas J Dermatol. 2021 May;62(2):e333-e334. doi: 10.1111/ajd.13504.
  7. Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection. Journal of the European Academy of Dermatology and Venereology: JEADV. 2020;34(9):e436-e437.
  8. Feldman SR, Freeman EE, Duffin KC, Corona R. COVID-19: Cutaneous manifestations and issues related to dermatologic care. UpToDate, Oct 22, 2021. Available at: https://www. uptodate.com/contents/coronavirusdisease-2019-covid-19- cutaneousmanifestations-and-issues-related-todermatologic- care. Accessed January, 2022.
  9. McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, Desai SR, French LE, Lim HW, Thiers BH, Hruza GJ, Blumenthal KG, Fox LP, Freeman EE. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092.
  10. Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol. 2009 Aug;61(2):303-18. doi: 10.1016/j. jaad.2008.07.045.
  11. Drago F, Ciccarese G, Parodi A. Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them? JAAD Case Rep. 2018 Sep 14;4(8):800-1. doi: 10.1016/j.jdcr.2018.04.002.
  12. Drago F, Ciccarese G, Javor S, Parodi A. Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature. J Eur Acad Dermatol Venereol. 2016 Mar;30(3):544-5. doi: 10.1111/jdv.12942.
  13. Marcantonio-Santa Cruz O, Vidal-Navarro A, Pesqué D, Giménez-Arnau A, Pujol R, Martin-Ezquerra G. Pityriasis rosea developing after COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e721-e722. doi: 10.1111/jdv.17498.
  14. Shin SH, Hong J, Hong S, Li K, Yoo K. Pityriasis rosea shortly after mRNA-1273 COVID-19 Vaccination. Int J Infect Dis. 2022 Jan;114:88-9. doi: 10.1016/j.ijid.2021.10.055.
  15. Abdullah L, Hasbani D, Kurban M, Abbas O. Pityriasis rosea after mRNA COVID-19 vaccination. Int J Dermatol. 2021 Sep;60(9):1150-1. doi: 10.1111/ijd.15700.
  16. Wang CS, Chen HH, Liu SH. Pityriasis rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review. J Formos Med Assoc. 2022 Jan 5;S0929- 6646(21)00595-7. doi: 10.1016/j.jfma.2021.12.028.
  17. Bostan E, Yalici-Armagan B. Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence? J Cosmet Dermatol. 2021 Jun;20(6):1566-7. doi: 10.1111/jocd.14035.
  18. Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection. Journal of the European Academy of Dermatology and Venereology: JEADV. 2020;34(9):e436-e437.